This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zwick, M. B. Articles by Burton, D. R. Search for Related Content PubMed PubMed Citation Articles by Zwick, M. B. Articles by Burton, D. R.

 Previous Article  |  Next Article 

Journal of Virology, May 2003, p. 5863-5876, Vol. 77, No. 10
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.10.5863-5876.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Molecular Features of the Broadly Neutralizing Immunoglobulin G1 b12 Required for Recognition of Human Immunodeficiency Virus Type 1 gp120

Michael B. Zwick,¹ Paul W. H. I. Parren,^1, Erica O. Saphire,^1,2 Sarah Church,¹ Meng Wang,¹ Jamie K. Scott,³ Philip E. Dawson,^4,5 Ian A. Wilson,^2,5 and Dennis R. Burton^1*

Departments of Immunology,¹ Molecular Biology,² Cell Biology,⁴ The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037,⁵ Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada³

Received 5 August 2002/ Accepted 14 February 2003

IgG1 b12 is a broadly neutralizing antibody against human immunodeficiency virus type 1 (HIV-1). The epitope recognized by b12 overlaps the CD4 receptor-binding site (CD4bs) on gp120 and has been a target for vaccine design. Determination of the three-dimensional structure of immunoglobulin G1 (IgG1) b12 allowed modeling of the b12-gp120 interaction in which the protruding third complementarity-determining region (CDR) of the heavy chain (H3) was crucial for antibody binding. In the present study, extensive mutational analysis of the antigen-binding site of Fab b12 was carried out to investigate the validity of the model and to identify residues important for gp120 recognition and, by inference, key to the anti-HIV-1 activity of IgG1 b12. In all, 50 mutations were tested: 40 in H3, 4 each in H2 and L1, and 2 in L3. The results suggest that the interaction of gp120 with H3 of b12 is crucially dependent not only on a Trp residue at the apex of the H3 loop but also on a number of residues at the base of the loop. The arrangement of these residues, including aromatic side chains and side chains that hydrogen bond across the base of the loop, may rigidify H3 for penetration of the recessed CD4-binding cavity. The results further emphasize the importance to gp120 binding of a Tyr residue at the apex of the H2 loop that forms a second finger-like structure and a number of Arg residues in L1 that form a positively charged, shelf-like structure. In general, the data are consistent with the b12-gp120 interaction model previously proposed. At the gene level, somatic mutation is seen to be crucial for the generation of many of the structural features described. The Fab b12 mutants were also tested against the b12 epitope-mimic peptide B2.1, and the reactivity profile had many similarities but also significant differences from that observed for gp120. The paratope map of b12 may facilitate the design of molecules that are able to elicit b12-like activities.

Present address: Genmab, 3584 CK Utrecht, The Netherlands.

This article has been cited by other articles:

• Miranda, L. R., Duval, M., Doherty, H., Seaman, M. S., Posner, M. R., Cavacini, L. A. (2007). The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain. J. Immunol. 178: 7132-7138 [Abstract] [Full Text]  
• Sheppard, N. C., Davies, S. L., Jeffs, S. A., Vieira, S. M., Sattentau, Q. J. (2007). Production and Characterization of High-Affinity Human Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in a Mouse Model Expressing Human Immunoglobulins. CVI 14: 157-167 [Abstract] [Full Text]  
• Kehoe, J. W., Velappan, N., Walbolt, M., Rasmussen, J., King, D., Lou, J., Knopp, K., Pavlik, P., Marks, J. D., Bertozzi, C. R., Bradbury, A. R. M. (2006). Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context. Mol. Cell. Proteomics 5: 2350-2363 [Abstract] [Full Text]  
• Juraja, S. M., Mulhern, T. D., Hudson, P. J., Hattarki, M. K., Carmichael, J. A., Nuttall, S. D. (2006). Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold. Protein Eng Des Sel 19: 231-244 [Abstract] [Full Text]  
• Burton, D. R., Stanfield, R. L., Wilson, I. A. (2005). Antibody vs. HIV in a clash of evolutionary titans. Proc. Natl. Acad. Sci. USA 102: 14943-14948 [Abstract] [Full Text]  
• Wilkinson, R. A., Piscitelli, C., Teintze, M., Cavacini, L. A., Posner, M. R., Lawrence, C. M. (2005). Structure of the Fab Fragment of F105, a Broadly Reactive Anti-Human Immunodeficiency Virus (HIV) Antibody That Recognizes the CD4 Binding Site of HIV Type 1 gp120. J. Virol. 79: 13060-13069 [Abstract] [Full Text]  
• Heap, C. J., Wang, Y., Pinheiro, T. J. T., Reading, S. A., Jennings, K. R., Dimmock, N. J. (2005). Analysis of a 17-amino acid residue, virus-neutralizing microantibody. J. Gen. Virol. 86: 1791-1800 [Abstract] [Full Text]  
• Xiang, S.-H., Farzan, M., Si, Z., Madani, N., Wang, L., Rosenberg, E., Robinson, J., Sodroski, J. (2005). Functional Mimicry of a Human Immunodeficiency Virus Type 1 Coreceptor by a Neutralizing Monoclonal Antibody. J. Virol. 79: 6068-6077 [Abstract] [Full Text]  
• Hamburger, A. E., Kim, S., Welch, B. D., Kay, M. S. (2005). Steric Accessibility of the HIV-1 gp41 N-trimer Region. J. Biol. Chem. 280: 12567-12572 [Abstract] [Full Text]  
• Holl, V., Hemmerter, S., Burrer, R., Schmidt, S., Bohbot, A., Aubertin, A.-M., Moog, C. (2004). Involvement of Fc{gamma}R I (CD64) in the Mechanism of HIV-1 Inhibition by Polyclonal IgG Purified from Infected Patients in Cultured Monocyte-Derived Macrophages. J. Immunol. 173: 6274-6283 [Abstract] [Full Text]  
• Zhang, M.-Y., Xiao, X., Sidorov, I. A., Choudhry, V., Cham, F., Zhang, P. F., Bouma, P., Zwick, M., Choudhary, A., Montefiori, D. C., Broder, C. C., Burton, D. R., Quinnan, G. V. Jr., Dimitrov, D. S. (2004). Identification and Characterization of a New Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody. J. Virol. 78: 9233-9242 [Abstract] [Full Text]  
• Pinter, A., Honnen, W. J., He, Y., Gorny, M. K., Zolla-Pazner, S., Kayman, S. C. (2004). The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection. J. Virol. 78: 5205-5215 [Abstract] [Full Text]  
• McCaffrey, R. A., Saunders, C., Hensel, M., Stamatatos, L. (2004). N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies. J. Virol. 78: 3279-3295 [Abstract] [Full Text]  
• Zwick, M. B., Komori, H. K., Stanfield, R. L., Church, S., Wang, M., Parren, P. W. H. I., Kunert, R., Katinger, H., Wilson, I. A., Burton, D. R. (2004). The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5. J. Virol. 78: 3155-3161 [Abstract] [Full Text]